Christensen King & Associates Investment Services’s Outlook Therapeutics OTLK Stock Holding History

Christensen King & Associates Investment Services’s Portfolio OTLK Stock Details OTLK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45K	Hold	28,327	–	–	0.02%	108
2026 Q1	$5.83K	Hold	28,327	–	–	﹤0.01%	105
2025 Q4	$44.8K	Buy	28,327 +1,119	+4%	+$1.79K	0.02%	106
2025 Q3	$28.8K	Buy	27,208 +2,878	+12%	+$4.98K	0.01%	106
2025 Q2	$38.9K	Buy	24,330 +12,420	+104%	+$19.8K	0.02%	101
2025 Q1	$16.7K	Buy	11,910 +1,334	+13%	+$2.34K	0.01%	97
2024 Q4	$15.5K	Buy	10,576 +300	+3%	+$1.23K	0.01%	92
2024 Q3	$54.9K	Buy	+10,276	New	+$75.2K	0.03%	99
2024 Q1	–	Sell	-8,180	Closed	-$64.5K	–	99
2023 Q4	$64.5K	Buy	+8,180	New	+$69.2K	0.03%	93

Other funds holding OTLK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GWM

Gilpin Wealth Management Denver, Colorado $145M AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

WMP

Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

FCC

Flower City Capital Pittsford, New York $227M AUM 23.31% 1-Year Est. Return

Christensen King & Associates Investment Services's OTLK Position: Q2 2026 in Review

Christensen King & Associates Investment Services held its Outlook Therapeutics (OTLK) position steady in Q2 2026 at 28,327 shares worth $45K. The position accounts for 0.02% of the portfolio, ranked #108.

Christensen King & Associates Investment Services first reported a position in OTLK in Q4 2023 and has held it in 9 quarters since. The position peaked at $64.5K in Q4 2023. 27 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

Christensen King & Associates Investment Services held 28,327 shares of Outlook Therapeutics worth $45K as of Q2 2026.
Christensen King & Associates Investment Services left its Outlook Therapeutics share count unchanged in Q2 2026.
Outlook Therapeutics made up 0.02% of Christensen King & Associates Investment Services's portfolio in Q2 2026, its #108 holding.
Christensen King & Associates Investment Services first reported a position in Outlook Therapeutics in Q4 2023 and has held it in 9 quarters since.
Christensen King & Associates Investment Services's Outlook Therapeutics position peaked at $64.5K in Q4 2023.
27 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Christensen King & Associates Investment Services's 13F filing for Q2 2026, filed 14 Jul 2026.